Smart Immune Doses First Leukemia Patients with ProTcell Therapy SMART101 in ReSET-02 Phase I/II Trial
September 27, 2023
On the occasion of its selection among the French Tech Health 20 winners, Karine Rossignol, CEO and Jérémy CFO/CBO were interviewed by various media.
Quote in Les Echos
Quote in Le Figaro
Article in Biotech Finances
TV appearance in BFM Tech&Co